Bristol-Myers Squibb Co (BSP:BMYB34) Cyclically Adjusted FCF per Share: R$29.73 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:BMYB34 Bristol-Myers Squibb Co BSP:BMYB34
70 GF Score
Price R$310.62
GF Value R$274.31
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share?

Bristol-Myers Squibb Co BSP:BMYB34 70 Cyclically Adjusted FCF per Share is R$29.73 as of Mar. 2026. GuruFocus rates BSP:BMYB34 with a GF Score™ of 70/100 and a GF Value™ of R$274.31 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was R$1.934. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$29.73 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bristol-Myers Squibb Co's average Cyclically Adjusted FCF Growth Rate was 14.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 13.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bristol-Myers Squibb Co was 14.70% per year. The lowest was -1.70% per year. And the median was 7.50% per year.

As of today (2026-07-27), Bristol-Myers Squibb Co's current stock price is R$310.62. Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was R$29.73. Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF of today is 10.45.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bristol-Myers Squibb Co was 40.22. The lowest was 7.74. And the median was 19.59.


Bristol-Myers Squibb Co  (BSP:BMYB34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=310.62/29.73
=10.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bristol-Myers Squibb Co was 40.22. The lowest was 7.74. And the median was 19.59.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Related Terms


Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.01 20.50 21.38 31.62 31.49

Bristol-Myers Squibb Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.16 29.13 30.06 31.49 29.73

BSP:BMYB34 vs PFE, GILD, AMGN: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF falls into.


BSP:BMYB34
70GF Score
Bristol-Myers Squibb Co BSP:BMYB34
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bristol-Myers Squibb Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.934/330.2130*330.2130
=1.934

Current CPI (Mar. 2026) = 330.2130.

Bristol-Myers Squibb Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.363 241.018 0.497
201609 2.060 241.428 2.818
201612 2.136 241.432 2.921
201703 1.067 243.801 1.445
201706 2.668 244.955 3.597
201709 2.763 246.819 3.697
201712 1.731 246.524 2.319
201803 1.871 249.554 2.476
201806 1.980 251.989 2.595
201809 2.650 252.439 3.466
201812 7.745 251.233 10.180
201903 2.783 254.202 3.615
201906 4.456 256.143 5.745
201909 5.965 256.759 7.671
201912 4.083 256.974 5.247
202003 8.117 258.115 10.384
202006 10.001 257.797 12.810
202009 4.985 260.280 6.324
202012 7.018 260.474 8.897
202103 9.083 264.877 11.323
202106 6.364 271.696 7.735
202109 11.758 274.310 14.154
202112 9.515 278.802 11.270
202203 8.184 287.504 9.400
202206 4.672 296.311 5.207
202209 8.398 296.808 9.343
202212 7.317 296.797 8.141
202303 6.636 301.836 7.260
202306 3.759 305.109 4.068
202309 10.550 307.789 11.319
202312 9.453 306.746 10.176
202403 6.277 312.332 6.636
202406 5.479 314.175 5.759
202409 14.361 315.301 15.040
202412 12.205 315.605 12.770
202503 4.781 319.799 4.937
202506 9.677 322.561 9.907
202509 15.758 324.800 16.021
202512 4.292 324.054 4.374
202603 1.934 330.213 1.934

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of R$29.73 mean?
Bristol-Myers Squibb Co (BSP:BMYB34) has a Cyclically Adjusted FCF per Share of R$29.73 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors.
Is Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share too high?
Bristol-Myers Squibb Co's current Cyclically Adjusted FCF per Share is R$29.73. Overall, Bristol-Myers Squibb Co has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share compare to PFE and GILD?
Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share of R$29.73 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors. Bristol-Myers Squibb Co's current Cyclically Adjusted FCF per Share is R$29.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (BSP:BMYB34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$274.31, compared to a current price of R$310.62 — trading 13.2% above its estimated fair value. The current Cyclically Adjusted FCF per Share is R$29.73. Bristol-Myers Squibb Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Bristol-Myers Squibb Co (BSP:BMYB34), the current Cyclically Adjusted FCF per Share is R$29.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (BSP:BMYB34) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of R$310.62 is trading 13.2% above its estimated GF Value™ of R$274.31. GuruFocus considers Bristol-Myers Squibb Co to be Modestly Overvalued.

Key valuation signals for BSP:BMYB34:

  • Cyclically Adjusted FCF per Share: R$29.73
  • GF Value™: R$274.31 vs. price of R$310.62 (13.2% above fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the BSP:BMYB34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
70GF Score

Get the complete analysis for BSP:BMYB34

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$310.62
Price
R$274.31
GF Value